Julian D. Huffman

Array ( [id] => 4612118 [patent_doc_number] => 07988956 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-02 [patent_title] => 'Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)' [patent_app_type] => utility [patent_app_number] => 12/559320 [patent_app_country] => US [patent_app_date] => 2009-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6971 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/988/07988956.pdf [firstpage_image] =>[orig_patent_app_number] => 12559320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6628137 [patent_doc_number] => 20100004198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'POLYSACCHARIDE GEL FORMULATION HAVING INCREASED LONGEVITY' [patent_app_type] => utility [patent_app_number] => 12/558270 [patent_app_country] => US [patent_app_date] => 2009-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6171 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004198.pdf [firstpage_image] =>[orig_patent_app_number] => 12558270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6306496 [patent_doc_number] => 20100069315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'METHOD AND MEDICAMENT FOR TREATING OCULAR INFECTIONS' [patent_app_type] => utility [patent_app_number] => 12/555509 [patent_app_country] => US [patent_app_date] => 2009-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5019 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20100069315.pdf [firstpage_image] =>[orig_patent_app_number] => 12555509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8516715 [patent_doc_number] => 20120316122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-13 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS FOR COMBATING THROMBOTIC DISEASES AND THEIR PREPARATION AND USES' [patent_app_type] => utility [patent_app_number] => 13/394375 [patent_app_country] => US [patent_app_date] => 2009-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15890 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13394375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6163029 [patent_doc_number] => 20110160155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'COMPOSITION AND USE OF A LONG-ACTING ORAL BIOADHESIVE ENDOPARASITICIDE GEL BASED ON DORAMECTIN' [patent_app_type] => utility [patent_app_number] => 13/062419 [patent_app_country] => US [patent_app_date] => 2009-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2149 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160155.pdf [firstpage_image] =>[orig_patent_app_number] => 13062419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6477812 [patent_doc_number] => 20100041618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => '6-11 Bridged Oxime Erythromycin Derivatives' [patent_app_type] => utility [patent_app_number] => 12/543155 [patent_app_country] => US [patent_app_date] => 2009-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16579 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041618.pdf [firstpage_image] =>[orig_patent_app_number] => 12543155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6256771 [patent_doc_number] => 20100029551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'Treatment Of Inflammatory Lung Conditions With Aerosolized Macrolide Antibiotics' [patent_app_type] => utility [patent_app_number] => 12/533779 [patent_app_country] => US [patent_app_date] => 2009-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12485 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029551.pdf [firstpage_image] =>[orig_patent_app_number] => 12533779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6327126 [patent_doc_number] => 20100197627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'PANCREATIC CANCER TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/512917 [patent_app_country] => US [patent_app_date] => 2009-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5931 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20100197627.pdf [firstpage_image] =>[orig_patent_app_number] => 12512917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6477825 [patent_doc_number] => 20100041619 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'Lasonolide compounds as reagents for inducing premature chromosome condensation and methods for treating disorders' [patent_app_type] => utility [patent_app_number] => 12/462005 [patent_app_country] => US [patent_app_date] => 2009-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19993 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041619.pdf [firstpage_image] =>[orig_patent_app_number] => 12462005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6102604 [patent_doc_number] => 20110166097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'TAXANE COMPOUNDS FOR TREATING EYE DISEASE' [patent_app_type] => utility [patent_app_number] => 13/002596 [patent_app_country] => US [patent_app_date] => 2009-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7744 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20110166097.pdf [firstpage_image] =>[orig_patent_app_number] => 13002596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8875821 [patent_doc_number] => 08470787 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-25 [patent_title] => 'Hydrates of erythromycin salts, preparation and use thereof' [patent_app_type] => utility [patent_app_number] => 13/003397 [patent_app_country] => US [patent_app_date] => 2009-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8085 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 173 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13003397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064199 [patent_doc_number] => 20110201572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'PHARMACEUTICAL COMPOSITION WITH GLYCOSAMINOGLYCANS AND USE THEREOF IN THE TREATMENT OF CHRONIC ULCERS' [patent_app_type] => utility [patent_app_number] => 13/001895 [patent_app_country] => US [patent_app_date] => 2009-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 19383 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201572.pdf [firstpage_image] =>[orig_patent_app_number] => 13001895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5464377 [patent_doc_number] => 20090324577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => '6-11 Bicyclic Ketolide Derivatives' [patent_app_type] => utility [patent_app_number] => 12/493847 [patent_app_country] => US [patent_app_date] => 2009-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51014 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20090324577.pdf [firstpage_image] =>[orig_patent_app_number] => 12493847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6163021 [patent_doc_number] => 20110160151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'Novel Acetates of 2-Deoxy Monosaccharides with Anticancer Activity' [patent_app_type] => utility [patent_app_number] => 13/003429 [patent_app_country] => US [patent_app_date] => 2009-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14239 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160151.pdf [firstpage_image] =>[orig_patent_app_number] => 13003429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6355446 [patent_doc_number] => 20100022469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'ANTHELMINTHIC FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 12/490965 [patent_app_country] => US [patent_app_date] => 2009-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10155 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022469.pdf [firstpage_image] =>[orig_patent_app_number] => 12490965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9020447 [patent_doc_number] => 08530433 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-10 [patent_title] => 'Use of icariside II in manufacture of products for preventing or treating male or female sexual dysfunction' [patent_app_type] => utility [patent_app_number] => 12/997423 [patent_app_country] => US [patent_app_date] => 2009-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 10 [patent_no_of_words] => 5592 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12997423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5569419 [patent_doc_number] => 20090252797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'TOPICAL APPLICATION OF IVERMECTIN FOR THE TREATMENT OF DERMATOLOGICAL CONDITIONS/AFFLICTIONS' [patent_app_type] => utility [patent_app_number] => 12/483604 [patent_app_country] => US [patent_app_date] => 2009-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4379 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20090252797.pdf [firstpage_image] =>[orig_patent_app_number] => 12483604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6048490 [patent_doc_number] => 20110207687 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'FULVIC ACID AND ANTIBIOTIC COMBINATION' [patent_app_type] => utility [patent_app_number] => 12/996480 [patent_app_country] => US [patent_app_date] => 2009-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3583 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207687.pdf [firstpage_image] =>[orig_patent_app_number] => 12996480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5945118 [patent_doc_number] => 20110105738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'DIARYL HEPATONOID-BASED COMPOUNDS USEFUL AS VIRUS INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/996302 [patent_app_country] => US [patent_app_date] => 2009-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9926 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105738.pdf [firstpage_image] =>[orig_patent_app_number] => 12996302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8028269 [patent_doc_number] => 08143212 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-27 [patent_title] => 'Dalbavancin compositions for treatment of bacterial infections' [patent_app_type] => utility [patent_app_number] => 12/476785 [patent_app_country] => US [patent_app_date] => 2009-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 64 [patent_no_of_words] => 64579 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/143/08143212.pdf [firstpage_image] =>[orig_patent_app_number] => 12476785 [rel_patent_id] =>[rel_patent_doc_number] =>)